| scholarly article | Q13442814 |
| P356 | DOI | 10.1152/JAPPLPHYSIOL.00873.2009 |
| P698 | PubMed publication ID | 20056850 |
| P2093 | author name string | Per Larsson | |
| Björn Bake | |||
| Ekaterina Mirgorodskaya | |||
| Anna-Carin Olin | |||
| Ann-Charlotte Almstrand | |||
| Evert Ljungström | |||
| Anna Bredberg | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 584-588 | |
| P577 | publication date | 2010-01-07 | |
| P1433 | published in | Journal of Applied Physiology | Q1091719 |
| P1476 | title | Effect of airway opening on production of exhaled particles | |
| P478 | volume | 108 |
| Q88646514 | A feasibility study into adenosine triphosphate measurement in exhaled breath condensate: a potential bedside method to monitor alveolar deformation |
| Q38945285 | Airborne spread of infectious agents in the indoor environment |
| Q39063769 | Application of drug testing using exhaled breath for compliance monitoring of drug addicts in treatment |
| Q39606013 | Bioaerosol production by patients with tuberculosis during normal tidal breathing: implications for transmission risk |
| Q38105070 | Biomarkers for gastroesophageal reflux in respiratory diseases |
| Q37513637 | Characteristics of exhaled particle production in healthy volunteers: possible implications for infectious disease transmission |
| Q56981438 | Characteristics of exhaled particle production in healthy volunteers: possible implications for infectious disease transmission |
| Q34985411 | Characterizations of particle size distribution of the droplets exhaled by sneeze |
| Q96953157 | Coronavirus Infection Prevention by Wearing Masks |
| Q104469255 | Cough-independent production of viable Mycobacterium tuberculosis in bioaerosol |
| Q46578234 | Detection of drugs of abuse in exhaled breath from users following recovery from intoxication |
| Q91911951 | Documentary Research of Human Respiratory Droplet Characteristics |
| Q92967199 | Effect of voicing and articulation manner on aerosol particle emission during human speech |
| Q35988934 | Exhaled breath condensates: analyzing the expiratory plume. |
| Q60912198 | Exhaled particles and small airways |
| Q51566950 | Exhaled particles as markers of small airway inflammation in subjects with asthma. |
| Q47551698 | Infectious virus in exhaled breath of symptomatic seasonal influenza cases from a college community. |
| Q89602017 | Influenza A viruses are transmitted via the air from the nasal respiratory epithelium of ferrets |
| Q28394356 | Influenza aerosols in UK hospitals during the H1N1 (2009) pandemic--the risk of aerosol generation during medical procedures |
| Q45530405 | Inspiratory and expiratory aerosol deposition in the upper airway |
| Q92915192 | Intra-individual variation of particles in exhaled air and of the contents of Surfactant protein A and albumin |
| Q92394021 | Is cough really necessary for TB transmission? |
| Q28821832 | Low Levels of Exhaled Surfactant Protein A Associated With BOS After Lung Transplantation |
| Q98385704 | Managing humidity support to intubated ventilated patients with COVID-19 |
| Q58789466 | Markers of Oxidative Stress in the Exhaled Breath Condensate of Workers Handling Nanocomposites |
| Q89704524 | Mechanically ventilated patients exhibit decreased particle flow in exhaled breath as compared to normal breathing patients |
| Q37520959 | Particle size concentration distribution and influences on exhaled breath particles in mechanically ventilated patients |
| Q38040600 | Physiological measurement of the small airways |
| Q47828689 | Quantification of cocaine and metabolites in exhaled breath by liquid chromatography-high-resolution mass spectrometry following controlled administration of intravenous cocaine. |
| Q23923701 | Quantity and size distribution of cough-generated aerosol particles produced by influenza patients during and after illness |
| Q37267994 | Respiratory symptoms, sleep-disordered breathing and biomarkers in nocturnal gastroesophageal reflux |
| Q42275608 | Respiratory virus RNA is detectable in airborne and droplet particles. |
| Q41616495 | Rhinoviruses significantly affect day-to-day respiratory symptoms of children with asthma. |
| Q34554269 | Sampling and detection of airborne influenza virus towards point-of-care applications |
| Q51685575 | Single-breath analysis using a novel simple sampler and capillary electrophoresis with contactless conductometric detection. |
| Q28396135 | Surfactant Protein A in Exhaled Endogenous Particles Is Decreased in Chronic Obstructive Pulmonary Disease (COPD) Patients: A Pilot Study |
| Q90313529 | Surfactant Protein A in particles in exhaled air (PExA), bronchial lavage and bronchial wash - a methodological comparison |
| Q35941653 | The Relationship of Mucus Concentration (Hydration) to Mucus Osmotic Pressure and Transport in Chronic Bronchitis |
| Q95600578 | The flow physics of COVID-19 |
| Q37811300 | The role of particle size in aerosolised pathogen transmission: a review |
Search more.